- Is Blood Cancer Research FDN a tax-exempt 501(c)(3)?
- Yes. Blood Cancer Research FDN is recognised by the IRS as a 501(c)(3) organisation (EIN 36-4330967). The IRS recognised Blood Cancer Research FDN as tax-exempt in February 2000.
- What is Blood Cancer Research FDN's EIN?
- Blood Cancer Research FDN's Employer Identification Number (EIN) is 36-4330967. The EIN was assigned by the IRS in February 2000. Donors and grantmakers use the EIN to verify tax-exempt status with the IRS.
- What does Blood Cancer Research FDN do?
- To promote, fund, and support Research into causes, treatments and cure for et, pv and mf.
- Where is Blood Cancer Research FDN located?
- Blood Cancer Research FDN is located at PO Box 10743, Chicago, IL, 60610.
- When was Blood Cancer Research FDN founded or recognised by the IRS?
- Blood Cancer Research FDN was recognised by the IRS as a tax-exempt organisation in February 2000. The IRS ruling date is the earliest authoritative date available for most US nonprofits.
- What is Blood Cancer Research FDN's annual revenue?
- On its most recent Form 990 (fiscal year 2024), Blood Cancer Research FDN reported $3.6M in total revenue and $3.8M in total expenses.
- Has Blood Cancer Research FDN been auto-revoked by the IRS?
- No. Blood Cancer Research FDN (EIN 36-4330967) does not appear on the IRS Auto-Revocation List. Givalgo Discover cross-references the IRS Auto-Revocation List on every profile load; if status changes, this page reflects it.
- Is Blood Cancer Research FDN listed in IRS Publication 78?
- Yes. Blood Cancer Research FDN is listed in IRS Publication 78 as an organisation eligible to receive tax-deductible charitable contributions. Pub 78 status is the canonical IRS signal that donations to an org are deductible.
